搜索临床试验以:nal-IRI /实验
总计18177个结果
-
Alnylam Pharmaceuticals主动,不招人转甲状腺素蛋白淀粉样变性 (ATTR) 伴心肌病美国, 波兰, 阿根廷, 澳大利亚, 比利时, 法国, 德国, 日本, 荷兰, 葡萄牙, 西班牙, 瑞典, 英国, 加拿大, 捷克语, 丹麦, 匈牙利, 爱尔兰, 挪威, 大韩民国, 奥地利, 克罗地亚, 以色列, 拉脱维亚, 立陶宛, 秘鲁
-
Reckitt Benckiser Healthcare (UK) LimitedNovotech (Australia) Pty Limited完全的
-
Vienna Institute for Research in Ocular Surgery完全的
-
The General Authority for Teaching Hospitals and...完全的
-
Wuxi No. 4 People's Hospital未知
-
Stryker Trauma GmbHGlobal Research Solutions; Stryker Osteosynthesis完全的
-
Ionis Pharmaceuticals, Inc.Akcea Therapeutics完全的
-
Hospital Universitari Vall d'Hebron Research InstituteParc Sanitari Sant Joan de Déu; Universitat Autonoma de Barcelona完全的
-
London School of Hygiene and Tropical MedicineSangath; University College, London; University of Liverpool; Human Development Research Foundation...未知
-
University Hospital, Montpellier终止
-
University of Alabama at BirminghamChildren's Hospital Medical Center, Cincinnati完全的
-
Third Affiliated Hospital, Sun Yat-Sen UniversityPeking University; First People's Hospital of Foshan; Shenzhen Third People's Hospital未知
-
Case Comprehensive Cancer Center完全的
-
United States Army Research Institute of Environmental...终止
-
Norwegian University of Science and TechnologyOslo University Hospital; Helse Stavanger HF; Haukeland University Hospital; Førde Central Hospital 和其他合作者完全的
-
University of EdinburghChief Scientist Office of the Scottish Government完全的
-
AIO-Studien-gGmbHServier Deutschland GmbH; Crolll Gmbh主动,不招人
-
Stryker Trauma GmbHGlobal Research Solutions完全的
-
Peking UniversityHuantai Maternal and Child Health Care Hospital未知
-
National Center for Research Resources (NCRR)未知
-
Riphah International University完全的